Get free PhD updates, every week | SIGN UP NOW Get free PhD updates, every week | SIGN UP NOW

We have 297 therapeutic PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


therapeutic PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

We have 297 therapeutic PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

PhD saved successfully

Development of RNA-loaded lipid nanomedicines for therapeutic and vaccines applications

Project - Recent mRNA vaccine success has heralded a new era of RNA nanomedicines. A few challenges remain to realise the full potential of RNA nanomedicines for therapeutic or therapeutic vaccine applications, including translation efficiency, targeted delivery and stability. Read more

Identifying novel therapeutic targets in CMML

Chronic myelomonocytic leukaemia (CMML) is a clonal stem cell neoplasm defined by abnormal monocytosis and dysplasia. A quarter of CMML patients progress to acute myeloid leukaemia and these patients have dismal prognosis. Read more
Last chance to apply

Aptamer and nanoMIP Beacons for Russian Doll Style Recognition in Therapeutic Drug Monitoring

The Department of Pharmaceutical and Biomolecular Sciences at Liverpool John Moores is looking for a motivated PhD student with at least an upper 2nd class degree in Chemistry or related subject to work on an exciting CAM funded fellowship under the supervision of Dr Jon Ashley. Read more

Impaired autophagy signalling in cutaneous Squamous Cell Carcinoma (cSCC): a novel therapeutic target.

This is a PhD opportunity funded by the British Skin Foundation to investigate how autophagy deregulation could impact tumor formation in cutaneous Squamous Cell Carcinoma (cSCC), and to test the hypothesis that pharmacological modulation of this pathway can reduce cSCC development and progression. Read more

Chemical glycoengineering of therapeutic antibodies

Glycosylation is the most common posttranslational protein modification. Recombinant therapeutic glycoproteins (RTGs) such as monoclonal antibodies (mAbs) are decorated with complex glycans that determine not only their efficacy but also other critical parameters such as in vivo half-life, stability and antigenicity. Read more

Vascular endothelial glycocalyx dysfunction as a therapeutic target in sepsis-associated acute kidney injury

Sepsis is the leading cause of acute kidney injury (sAKI), associated with high morbidity and mortality.1,2 Unfortunately, there is no treatment for sAKI, current therapies are nonspecific and supportive of the vital organs. Read more

Therapeutic resolution of coronavirus (COVID-19) diseases by natural products

  Research Group: Pharmacology and Experimental Therapeutics
Coronavirus now labelled as Covid-19 has become a global pandemic affecting around 200 countries. Currently neither any cure nor any vaccine for Covid-19 has been established. Read more

Filtering Results